ICD-10-CM Billable Code

I70.544

Atherosclerosis of nonautologous biological bypass graft(s) of the left leg with ulceration of heel and midfoot

Clinical Classification Guidelines

Inclusion Terms

  • Atherosclerosis of nonautologous biological bypass graft(s) of left leg with ulceration of plantar surface of midfoot

Medical Intelligence & Overview

ICD-10 code I70.544 refers to a condition involving the narrowing or hardening of blood vessels in the leg, specifically affecting nonautologous biological bypass grafts on the left leg. This condition is associated with the development of ulcers on the heel and midfoot, which are common complications in individuals with compromised blood flow. Atherosclerosis—the buildup of fats, cholesterol, and other substances in and on the artery walls—can significantly impair circulation, leading to tissue damage and ulcer formation.

Causes & Symptoms

Clinical Causes: Progressive buildup of fatty deposits within the arteries (atherosclerosis) Repeated injury or trauma to the foot and heel Smoking, which damages blood vessel linings High cholesterol and lipid levels in the blood Diabetes mellitus, which accelerates vascular damage Hypertension or high blood pressure Poor blood circulation or peripheral vascular disease Previous vascular surgeries or grafts that may become narrowed or blocked

Key Symptoms: Ulcers on the heel and midfoot, especially on the plantar (bottom) surface Pain or tenderness in the affected area Discoloration or darkening of the skin near the ulcer Swelling or inflammation around the ulcer Reduced sensation or numbness in the foot Signs of infection, such as pus, increased redness, or warmth Coldness or pale appearance of the foot or leg

Diagnostic & Treatment

Diagnosis Path: Doctors typically evaluate this condition through clinical examination and imaging tests. The diagnostic process may include: - Physical assessment of the affected foot and leg - Doppler ultrasound to assess blood flow - Angiography (X-ray imaging using contrast dye) to visualize blood vessel blockages - Blood tests to check for risk factors like cholesterol and glucose levels - Wound assessment to determine ulcer severity and potential infection Successful diagnosis helps in planning appropriate treatment to improve blood flow and manage ulcers.

Treatment Protocols: Treatment strategies focus on restoring adequate blood circulation and promoting ulcer healing. Common approaches include: - Medical management of underlying risk factors, such as controlling diabetes, hypertension, and cholesterol - Wound care to protect ulcers from infection and facilitate healing, including cleaning, dressings, and possibly debridement - Medications to improve blood flow, such as vasodilators or antiplatelet agents - Foot off-loading to reduce pressure on ulcers - Surgical intervention, which may involve revision of grafts or bypass procedures, if necessary - Lifestyle modifications, like smoking cessation, regular foot examinations, and maintaining good glycemic control - In some cases, advanced wound therapies, such as hyperbaric oxygen therapy, may be considered It is essential for affected individuals to work closely with a healthcare team to develop a personalized care plan and prevent further complications.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is I70.544 a billable ICD-10 code?
Yes, I70.544 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report I70.544?
Clinical documentation must specify the nature of Atherosclerosis of nonautologous biological bypass graft(s) of the left leg with ulceration of heel and midfoot and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Clinical Meta Tags

nonautologous atherosclerosis ulceration bypass midfoot biological